These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16628706)

  • 1. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations.
    Teratani T; Yoshida H; Shiina S; Obi S; Sato S; Tateishi R; Mine N; Kondo Y; Kawabe T; Omata M
    Hepatology; 2006 May; 43(5):1101-8. PubMed ID: 16628706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
    Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
    Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors.
    Kim YS; Rhim H; Cho OK; Koh BH; Kim Y
    Eur J Radiol; 2006 Sep; 59(3):432-41. PubMed ID: 16690240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location.
    Francica G; Petrolati A; Di Stasio E; Pacella S; Stasi R; Pacella CM
    AJR Am J Roentgenol; 2012 Dec; 199(6):1393-401. PubMed ID: 23169736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for distant recurrence of hepatocellular carcinoma in the liver after complete coagulation by microwave or radiofrequency ablation.
    Izumi N; Asahina Y; Noguchi O; Uchihara M; Kanazawa N; Itakura J; Himeno Y; Miyake S; Sakai T; Enomoto N
    Cancer; 2001 Mar; 91(5):949-56. PubMed ID: 11251946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative radiofrequency ablation for hepatocellular carcinoma: long-term results in a large series.
    Kim YS; Rhim H; Lim HK; Choi D; Lee WJ; Jeon TY; Joh JW; Kim SJ
    Ann Surg Oncol; 2008 Jul; 15(7):1862-70. PubMed ID: 18463926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
    Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of postoperative recurrence of hepatocellular carcinoma with radiofrequency ablation comparing with repeated surgical resection].
    Ren ZG; Gan YH; Fan J; Chen Y; Wu ZQ; Qin LX; Ge NL; Zhou J; Xia JL; Wang YH; Ye QH; Wang L; Ye SL
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1614-6. PubMed ID: 19094752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial].
    Lü MD; Kuang M; Liang LJ; Xie XY; Peng BG; Liu GJ; Li DM; Lai JM; Li SQ
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):801-5. PubMed ID: 16681964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of laparoscopic radiofrequency ablation for hepatocellular carcinoma compared to percutaneous radiofrequency ablation with artificial ascites.
    Hirooka M; Kisaka Y; Uehara T; Ishida K; Kumagi T; Watanabe Y; Abe M; Matsuura B; Hiasa Y; Onji M
    Dig Endosc; 2009 Apr; 21(2):82-6. PubMed ID: 19691779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.
    Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT
    J Am Coll Surg; 2008 Jul; 207(1):20-9. PubMed ID: 18589357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation with hand-assisted laparoscopic surgery for the treatment of hepatocellular carcinoma in the caudate lobe.
    Ishiko T; Beppu T; Sugiyama S; Masuda T; Takahashi M; Komori H; Takamori H; Hirota M; Kanemitu K; Baba H
    Surg Laparosc Endosc Percutan Tech; 2008 Jun; 18(3):272-6. PubMed ID: 18574414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
    Chow DH; Sinn LH; Ng KK; Lam CM; Yuen J; Fan ST; Poon RT
    J Surg Oncol; 2006 Dec; 94(7):565-71. PubMed ID: 17048238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
    Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I
    Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy.
    Masuda T; Beppu T; Ishiko T; Horino K; Baba Y; Mizumoto T; Hayashi H; Okabe H; Horlad H; Doi K; Okabe K; Takamori H; Hirota M; Iyama K; Baba H
    J Hepatobiliary Pancreat Surg; 2008; 15(6):589-95. PubMed ID: 18987928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
    Cheung TT; Ng KK; Poon RT; Fan ST
    J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.
    Lencioni R; Crocetti L; Petruzzi P; Vignali C; Bozzi E; Della Pina C; Bargellini I; Cioni D; Oliveri F; De Simone P; Bartolozzi C; Brunetto M; Filipponi F
    J Hepatol; 2008 Aug; 49(2):217-22. PubMed ID: 18486261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe.
    Peng ZW; Liang HH; Chen MS; Zhang YJ; Li JQ; Zhang YQ; Lau WY
    Eur J Surg Oncol; 2008 Feb; 34(2):166-72. PubMed ID: 17851020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.